This summary was created by AI, based on 1 opinions in the last 12 months.
The Ensign Group, trading under the symbol ENSG-Q, has been experiencing a steady rise in its share prices, climbing from $30 to $36. As a small-cap company in the healthcare sector, it presents a price-to-earnings (PE) ratio of 23x, which indicates a moderate valuation relative to its earnings. Industry experts suggest that while the growth trajectory appears promising, careful analysis is essential, as the healthcare market can be unpredictable. Investors are advised to consider market dynamics and the company's operational strategies before making investment decisions, as these factors could significantly influence future performance.
The Ensign Group is a American stock, trading under the symbol ENSG-Q on the NASDAQ (ENSG). It is usually referred to as NASDAQ:ENSG or ENSG-Q
In the last year, 1 stock analyst published opinions about ENSG-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for The Ensign Group.
The Ensign Group was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for The Ensign Group.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of The Ensign Group published on Stockchase.
On 2025-02-04, The Ensign Group (ENSG-Q) stock closed at a price of $145.43.
A small-cap with a 23x PE in healthcare. Shares have climbed from $30 to $36.